Meta-analysis of 26 studies (27,933 MZ/SZ alpha-1 antitrypsin heterozygotes vs 547,961 controls): heterozygotes had higher odds of fibrosis (OR 2.14), cirrhosis (OR 2.24) and liver transplantation (OR 2.28), with modestly raised liver enzymes but similar steatosis.
Meta-analysisn = 575,894
Syanda et al. Meta-Analysis: Redefining Liver Disease Risk in Heterozygous Alpha-1 Antitrypsin Deficiency